Geode Capital Management, LLC Ac Immune Sa Transaction History

Geode Capital Management, LLC

$1.39 Trillion
Q2 2025

A detailed history of Geode Capital Management, LLC transactions in Ac Immune Sa stock. As of the latest transaction made, Geode Capital Management, LLC holds 63,601 shares of ACIU stock, worth $185,714. This represents 0.0% of its overall portfolio holdings.

Number of Shares

63,601

Previous 64,090 0.76%

Holding current value

$185,714

Previous $119,000 8.4%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 08, 2025	SELL	$1.48 - $2.2 $723 - $1,075	-489 Reduced 0.76%	63,601 $129,000
Q4 2024 Feb 12, 2025	BUY	$2.67 - $3.75 $15,469 - $21,727	5,794 Added 9.94%	64,090 $173,000
Q3 2024 Nov 12, 2024	BUY	$2.99 - $4.2 $10,462 - $14,695	3,499 Added 6.39%	58,296 $220,000
Q1 2024 May 13, 2024	BUY	$2.66 - $4.87 $36,928 - $67,610	13,883 Added 33.93%	54,797 $162,000
Q3 2023 Nov 13, 2023	BUY	$2.77 - $3.38 $10,514 - $12,830	3,796 Added 10.23%	40,914 $116,000
Q2 2021 Aug 13, 2021	BUY	$6.04 - $8.37 $9,966 - $13,810	1,650 Added 4.65%	37,118 $294,000
Q1 2021 May 12, 2021	BUY	$5.32 - $8.96 $64,600 - $108,801	12,143 Added 52.06%	35,468 $269,000
Q4 2020 Feb 12, 2021	SELL	$4.47 - $5.58 $93,892 - $117,207	-21,005 Reduced 47.38%	23,325 $120,000
Q3 2020 Nov 13, 2020	BUY	$4.78 - $9.06 $19,621 - $37,191	4,105 Added 10.21%	44,330 $216,000
Q2 2020 Aug 13, 2020	SELL	$6.57 - $8.3 $18,796 - $23,746	-2,861 Reduced 6.64%	40,225 $270,000
Q1 2020 May 14, 2020	BUY	$4.24 - $9.89 $45,736 - $106,683	10,787 Added 33.4%	43,086 $297,000
Q4 2019 Feb 13, 2020	SELL	$4.56 - $8.78 $94,013 - $181,017	-20,617 Reduced 38.96%	32,299 $275,000
Q3 2019 Nov 12, 2019	SELL	$4.8 - $5.89 $2,380 - $2,921	-496 Reduced 0.93%	52,916 $261,000
Q2 2019 Aug 14, 2019	BUY	$4.72 - $5.88 $1,170 - $1,458	248 Added 0.47%	53,412 $296,000
Q1 2019 May 14, 2019	BUY	$3.65 - $11.68 $3,394 - $10,862	930 Added 1.78%	53,164 $268,000
Q4 2018 Feb 13, 2019	SELL	$7.35 - $11.7 $9,268 - $14,753	-1,261 Reduced 2.36%	52,234 $493,000
Q3 2018 Nov 13, 2018	BUY	$7.88 - $16.45 $16,130 - $33,673	2,047 Added 3.98%	53,495 $427,000
Q2 2018 Aug 14, 2018	BUY	$8.17 - $10.9 $51,144 - $68,234	6,260 Added 13.85%	51,448 $478,000
Q1 2018 May 15, 2018	BUY	$10.34 - $13.78 $11,580 - $15,433	1,120 Added 2.54%	45,188 $467,000
Q4 2017 Feb 13, 2018	BUY	$10.37 - $12.85 $12,609 - $15,625	1,216 Added 2.84%	44,068 $564,000
Q3 2017 Nov 14, 2017	BUY	$7.06 - $11.2 $119,306 - $189,268	16,899 Added 65.11%	42,852 $484,000
Q2 2017 Aug 14, 2017	BUY	N/A	25,953	25,953 $228,000

Others Institutions Holding ACIU

# of Institutions

Shares Held

26.9M

Call Options Held

Put Options Held

28.5K

View Full List

About AC Immune SA

Ticker ACIU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 83,413,504
Market Cap $244M
Description
AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. Its SupraAntigen and Morphomer platforms are designed to generate vaccines, antibodies, and small molecules, which selectiv...

More about ACIU

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Geode Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Geode Capital Management, LLC with notifications on news.

Account

Geode Capital Management, LLC Ac Immune Sa Transaction History